For the past year, an AATS Task Force has addressed the question: “What would a quality assessment program look like if it were developed from the ground up in the 21st century?” In Saturday’s “Plenary Session – Quality and Outcomes,” Eugene H. Blackstone, MD, of the Cleveland Clinic Foundation, said: “This afternoon we answer the question by introducing you to the AATS Quality Assessment Program for the 21st century.” He presented the program on behalf of the Governance Committee of the new AATS Quality Program.
“This program was presented to the AATS Council in December and it was voted unanimously to pursue this initiative,” according to David Jones, MD, current AATS Secretary.
In summarizing the need for such a program, former AATS President, Craig Smith, MD, said “Inability to analyze actionable feedback in anything approaching real time is retarding the advancement of our profession by stunting innovation and collaboration.”
In 1994, the Association established its Scientific Achievement Award to recognize individuals who have made extraordinary scientific contributions to the field of cardiothoracic surgery. D. Craig Miller, MD, has been chosen as this year’s Scientific Achievement Award winner. He will join a list of only 13 other colleagues as a recipient of the highest scientific recognition the AATS can bestow upon a surgeon.
The AATS Lifetime Achievement Award will be presented during the Monday Presidential Plenary at 11:20 a.m. in Hall C.
The AATS Scientific Achievement Award will be presented during the Monday Presidential Plenary at 11:20 a.m. in Hall C.
A successful cardiothoracic surgeon “doesn’t exist in a vacuum” but is only as strong as the team built around him or her.
Building that successful team was the focus of Saturday’s “Cardiothoracic Careers College: Team Development” session. Moderators Thomas Varghese, MD, of the University of Utah, Salt Lake City, and Jennifer Romano, MD, of the University of Michigan, Ann Arbor, led the session looking at the components that go into building and maintaining a successful cardiothoracic surgery team.
The future of cardiothoracic surgery looks bright as clinical trials continue to push the envelope of the possible and bring innovation closer to clinical practice. The session “Looking to the Future: Clinical Trials, Education, and Evolution” featured presentations on some interesting new research developments.
Putting patients in the best possible position prior to surgery is worth the effort, and can reduce complications and improve patients’ quality of life, according to experts in the session “Perioperative Optimization: What’s the Rush? Let’s First Optimize.”
The AATS Foundation is a vital part of the American Association for Thoracic Surgery’s mission, providing a significant impact on a broad number of individuals by training the leaders of the future. Your support is critical to enhancing the skills and knowledge of the next generation of cardiothoracic surgeons throughout the world and continuing the advancement of global innovation in the specialty. Please make a gift to the AATS Foundation today. Donating to an AATS Foundation program helps to fulfill the mission of supporting cardiothoracic surgeons in research and education. Through the AATS 99th Annual Meeting, the Association has issued a matching grant of up to a total of $250,000. Every individual one-time gift of $5,000 or more will be doubled, making each dollar you contribute twice as valuable.
Lesion measurements at recurrence sites might be a useful prognosticator in malignant pleural mesothelioma (MPM) patients who local recurrence after multimodality therapy, according to a study presented by Walter Weder, MD, on behalf of Olivia Lauk, MD, in Saturday morning’s “Mesothelioma: How Much Surgery Is Enough?” session.
Deaths from prescription opioid overdose have quadrupled in the past 15 years, but there is little information evaluating the appropriate amount of opioids to be prescribed after cardiac surgery, according to Kathleen C. Clement, MD, who presented “Predictors of New Persistent Opioid Use After Coronary Artery Bypass Grafting,” on Saturday morning. She and her colleagues at Johns Hopkins University in Baltimore performed a database study to quantify the amount of outpatient opioids prescribed and to determine the incidence and risk factors for new persistent opioid use after coronary artery bypass graft (CABG).
The Saturday session “Aortic Root Surgery” featured presentations of innovative approaches and new thinking on aortic root surgery.
In the largest reported cohort of aortic root replacement after previous cardiac surgery, the reoperative Bentall procedure was associated with a significant operative risk, according to Amine Mazine, MD.